Literature DB >> 32703502

Autopsy of patients with COVID-19: A balance of fear and curiosity.

Klaus Hirschbühl1, Tina Schaller2, Elisabeth Kling3, Bruno Märkl2, Rainer Claus4.   

Abstract

Entities:  

Keywords:  Autopsy; COVID-19; Personal protective equipment (PPE); SARS-CoV-2

Mesh:

Year:  2020        PMID: 32703502      PMCID: PMC7261439          DOI: 10.1016/j.prp.2020.153039

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


× No keyword cloud information.
Corona virus disease 2019 (COVID-19) disease has become pandemic since December 2019. App. 15 % of those affected undergo a severe disease and 5–6 % are critical (respiratory failure, and/or multiple organ dysfunction/failure). COVID-19 pathogenesis is still not sufficiently understood. Thus, systematic examination is mandatory to comprehend extent and mechanisms of this novel disease. Autopsy is the only opportunity to macroscopically observe organs and take optimal samples for histological and molecular analyses. Thereby, autopsy is very likely superior over postmortem core needle biopsies. Consequently, several reports have recently demonstrated that autopsy based examinations generate important insights into the disease manifestations, the mechanisms of organ failure and the association with viral distribution [[1], [2], [3]]. While most Coronavirinae belong to hazard group 2 (HG2), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently been categorized as HG3 like the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), indicating that it can cause severe human disease and may be a serious hazard to contact persons. Thus, postmortem examinations in SARS-CoV-2 positive patients have to be considered high-risk infectious autopsies. Several publications and recommendations from official institutions (such as the Robert-Koch-Institut in Berlin for Germany) have generated a debate about weighing risks and benefits of autopsies in COVID-19 cases [[4], [5], [6]]. Institutional restrictions and personal concerns might be counterproductive and could significantly limit and delay research of this dramatic disease. The main route of transmission is by respiratory droplets released from infected persons. This is not a major concern when handling human remains or performing postmortem procedures. Transmission via surfaces appears less frequent and relevant. Taken together, evidence about the risk of getting infected during autopsies and workup of the specimens is lacking so far. Here, we report our experience from a series of full autopsies (including brain autopsy) of 17 patients with proven SARS-CoV-2 infection and COVID-19 at the University Medical Center Augsburg [3]. The study was approved by the local institutional review board (approval number 2020-18, April 20, 2020). Autopsies were always conducted by the identical team of four trained physicians without technical assistance between April 4 and 28, 2020, according to recommendations and published best practice for managing cases with HG3 pathogens [4,5]. Personal protective equipment (PPE) used for all autopsies included a surgical scrub suit and rubber boots, a hat to protect hair, safety goggles and a clear visor to protect the face, an FFP3 mask for respiratory protection, a waterproof gown, additional forearm protection, a plastic apron, cut-resistant glass fibre reinforced protective gloves and double surgical gloves as illustrated in Fig. 1 . PPE was disposed before leaving the autopsy suite. One physician acted as circulator assistant carrying out auxiliary tasks. Precautions included the use of a separate autopsy suite with whole room ventilation (IQ-Air Healthpro 250 NE, Switzerland). Postmortem testing for SARS-CoV-2 was done by antisense strand based reverse transcriptase polymerase chain reaction (RT-PCR) from nasopharyngeal, tracheal and bronchial swabs in all cases. At time of autopsy, 16 out of 17 patients were positive for SARS-CoV-2 at least at one site of the respiratory tract. After the last autopsy using the outlined PPE, all four physicians did not show any symptoms and were repeatedly tested negative for SARS-CoV-2 by oropharyngeal swabs and RT-PCR on May 8 and May 11, 2020. Serological testing by two different test kits (anti-SARS-CoV2 IgA and anti-SARS-CoV2 IgG, Euroimmun, Germany; Elecys anti-SARS-CoV2 IgG/IgM, Roche, Switzerland) was also negative for all four.
Fig. 1

Systematic layered representation of the personal protective equipment (PPE).

A) Basic layer of surgical scrub suit and rubber boots. B) Surgical hood for hair protection, safety goggles, respiratory protection by an FFP3 mask and cut-proof synthetic mesh gloves. C) Long fluid-resistant isolation gown, first layer of latex/nitrile gloves. D) Face shield, waterproof apron and additional forearm protection, second layer of latex/nitrile gloves.

Systematic layered representation of the personal protective equipment (PPE). A) Basic layer of surgical scrub suit and rubber boots. B) Surgical hood for hair protection, safety goggles, respiratory protection by an FFP3 mask and cut-proof synthetic mesh gloves. C) Long fluid-resistant isolation gown, first layer of latex/nitrile gloves. D) Face shield, waterproof apron and additional forearm protection, second layer of latex/nitrile gloves. In summary, we describe an autopsy procedure applicable to cases of COVID-19 and provide first evidence that postmortem examinations can be conducted safely in those patients when applying appropriate PPE. This report is the first of its kind on analyses of autopsy personnel tested negative by RT-PCR and serology. Our observations indicate that the risk of SARS-CoV-2 infection during autopsy might be overestimated and restrictions on postmortem examinations could be reconsidered. However, a systematic risk assessment for full autopsy, workup and examination of the specimens is still not available and needs to be completed. This is of particular interest since different pathologists/working groups in a number of different countries follow different standard operating procedures for autopsy of COVID-19 patients (Table 1 ). Taken together, it appears to be common sense to protect autopsy personnel during the procedure at least in the same fashion as personnel on wards specific for SARS-CoV-2 positive patients.
Table 1

Systematic comparison of recommended and reported safety measures (personal protective equipment, PPE) for autopsy studies with COVID-19 patients.

PPEBarton LM et al. (5)Menter T et al. (1)Hanley B et al. (4)CDCRKISchaller et al. (3)
Surgical scrub shirt, pants++
Rubber shoes/boots+++ (with metal toecaps)+++
Surgical hood+++++
N95 mask, FFP2/3 mask++++++
Eye protection (goggles/face shield)++++++
Cut-proof synthetic mesh gloves+++
Waterproof gown+hazmat suit++++
Gloves++++ (2 pairs)+ (at least one pair)+ (2 pairs)
Waterproof apron++++
Negative pressure autopsy suite / isolation room+++
Reverse flow air handling system++++
Shower room+
Miscellaniousdisposable body suithandsaw for skullelectric bone saw with vacuumIQ-Air Healthpro 250 NE room air purifier
shoe covers2 h before autopsy, instillation of 4% phosphate buffered formalin into mouth, nose, pharynx
3 M Versaflow powered air purifying respirators with M-Series headgear

Abbreviations: PPE, personal protective equipment; CDC, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; RKI, Robert-Koch-Institute, Berlin, Germany.

Systematic comparison of recommended and reported safety measures (personal protective equipment, PPE) for autopsy studies with COVID-19 patients. Abbreviations: PPE, personal protective equipment; CDC, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; RKI, Robert-Koch-Institute, Berlin, Germany.

Funding/Support

No third-party funding was received for this study.

CRediT authorship contribution statement

Klaus Hirschbühl: Methodology, Investigation, Writing - original draft. Tina Schaller: Methodology, Investigation, Formal analysis. Elisabeth Kling: Methodology, Investigation. Bruno Märkl: Conceptualization, Investigation, Resources, Writing - original draft, Visualization. Rainer Claus: Conceptualization, Methodology, Investigation, Writing - original draft, Supervision.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  6 in total

1.  Postmortem Examination of Patients With COVID-19.

Authors:  Tina Schaller; Klaus Hirschbühl; Katrin Burkhardt; Georg Braun; Martin Trepel; Bruno Märkl; Rainer Claus
Journal:  JAMA       Date:  2020-06-23       Impact factor: 56.272

Review 2.  Autopsy in suspected COVID-19 cases.

Authors:  Brian Hanley; Sebastian B Lucas; Esther Youd; Benjamin Swift; Michael Osborn
Journal:  J Clin Pathol       Date:  2020-03-20       Impact factor: 3.411

3.  Multiorgan and Renal Tropism of SARS-CoV-2.

Authors:  Victor G Puelles; Marc Lütgehetmann; Maja T Lindenmeyer; Jan P Sperhake; Milagros N Wong; Lena Allweiss; Silvia Chilla; Axel Heinemann; Nicola Wanner; Shuya Liu; Fabian Braun; Shun Lu; Susanne Pfefferle; Ann S Schröder; Carolin Edler; Oliver Gross; Markus Glatzel; Dominic Wichmann; Thorsten Wiech; Stefan Kluge; Klaus Pueschel; Martin Aepfelbacher; Tobias B Huber
Journal:  N Engl J Med       Date:  2020-05-13       Impact factor: 91.245

4.  COVID-19 Autopsies, Oklahoma, USA.

Authors:  Lisa M Barton; Eric J Duval; Edana Stroberg; Subha Ghosh; Sanjay Mukhopadhyay
Journal:  Am J Clin Pathol       Date:  2020-05-05       Impact factor: 2.493

Review 5.  The autopsy debate during the COVID-19 emergency: the Italian experience.

Authors:  Anna Sapino; Fabio Facchetti; Emanuela Bonoldi; Andrea Gianatti; Mattia Barbareschi
Journal:  Virchows Arch       Date:  2020-06       Impact factor: 4.064

6.  Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction.

Authors:  Thomas Menter; Jasmin D Haslbauer; Ronny Nienhold; Spasenija Savic; Helmut Hopfer; Nikolaus Deigendesch; Stephan Frank; Daniel Turek; Niels Willi; Hans Pargger; Stefano Bassetti; Joerg D Leuppi; Gieri Cathomas; Markus Tolnay; Kirsten D Mertz; Alexandar Tzankov
Journal:  Histopathology       Date:  2020-07-05       Impact factor: 5.087

  6 in total
  2 in total

Review 1.  Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?

Authors:  Danny Jonigk; Christopher Werlein; Saskia von Stillfried; Peter Boor; Till Acker; Martin Aepfelbacher; Kerstin U Amann; Gustavo Baretton; Peter Barth; Rainer M Bohle; Andreas Büttner; Reinhard Büttner; Reinhard Dettmeyer; Philip Eichhorn; Sefer Elezkurtaj; Irene Esposito; Katja Evert; Matthias Evert; Falko Fend; Nikolaus Gaßler; Stefan Gattenlöhner; Markus Glatzel; Heike Göbel; Elise Gradhand; Torsten Hansen; Arndt Hartmann; Axel Heinemann; Frank L Heppner; Julia Hilsenbeck; David Horst; Jan C Kamp; Gita Mall; Bruno Märkl; Benjamin Ondruschka; Jessica Pablik; Susanne Pfefferle; Alexander Quaas; Helena Radbruch; Christoph Röcken; Andreas Rosenwald; Wilfried Roth; Martina Rudelius; Peter Schirmacher; Julia Slotta-Huspenina; Kevin Smith; Linna Sommer; Konrad Stock; Philipp Ströbel; Stephanie Strobl; Ulf Titze; Gregor Weirich; Joachim Weis; Martin Werner; Claudia Wickenhauser; Thorsten Wiech; Peter Wild; Tobias Welte
Journal:  Virchows Arch       Date:  2022-04-01       Impact factor: 4.535

2.  Viral mapping in COVID-19 deceased in the Augsburg autopsy series of the first wave: A multiorgan and multimethodological approach.

Authors:  Klaus Hirschbühl; Sebastian Dintner; Martin Beer; Claudia Wylezich; Jürgen Schlegel; Claire Delbridge; Lukas Borcherding; Jirina Lippert; Stefan Schiele; Gernot Müller; Dimitra Moiraki; Oliver Spring; Michael Wittmann; Elisabeth Kling; Georg Braun; Thomas Kröncke; Rainer Claus; Bruno Märkl; Tina Schaller
Journal:  PLoS One       Date:  2021-07-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.